Skip to content
S4774Senate2021-2022 SessionSame asA6067

Label Opioids With Warnings

Official title

“Relates to labeling prescription bottles of opioids”

Sponsor Elijah Reichlin-MelnickSD-38+1 co-sponsorAffects Health
Status
In Senate Committee
Health
Impact
4/10
Low
Passage
0%

Bill progress

Step 2 of 7

In committee · Health

What's happening

This bill requires opioid prescription bottles in New York to have a warning label about addiction, depression, and overdose risks.

Why it matters

  1. Raises public awareness at the point of use. By requiring a clear warning label directly on opioid prescription bottles, the bill ensures that patients and caregivers are immediately confronted with information about addiction, depression, and overdose risks—potentially prompting more careful usage and vigilance.

  2. Promotes patient-provider communication. The required label specifically advises patients to consult their pharmacist or physician before use, which could lead to more conversations about safe use, alternative treatments, and mental health monitoring.

  3. May support broader public health and harm reduction goals. The measure could help destigmatize the discussion of opioid addiction and mental health concerns by making these issues a routine part of medication dispensing, possibly encouraging those at risk to seek help sooner.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Label Opioids With Warnings

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Elijah Reichlin-Melnick

Senator · Senate District 38

Chair, Procurement And Contracts

1 Co-sponsor

History

  1. Referred to health
  2. Referred to health

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A6067Assembly

Warn Opioid Users on Bottles

In Assembly Committee · Health · Sponsor Edward Braunstein

Impact 3 · Low0% to pass

Full text

1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

4774

2021-2022 Regular Sessions

IN SENATE

February 11, 2021

Introduced by Sen. REICHLIN-MELNICK -- read twice and ordered printed, and when printed to be committed to the Committee on Health

AN ACT to amend the public health law, in relation to labeling prescription bottles of opioids

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Subdivision 2 of section 3333 of the public health law is amended by adding a new paragraph (d) to read as follows:

(d) In addition to the other requirements of this subdivision, where the controlled substance being dispensed is an opioid, there shall be affixed to the container a label upon which is indelibly typed, printed, or otherwise legibly written "Warning. This drug is highly addictive and may cause depression and overdose. Please consult your pharmacist or physician before using."

§ 2. This act shall take effect on the ninetieth day after it shall have become a law. Effective immediately, the addition, amendment and/or repeal of any rule or regulation necessary for the implementation of this act on its effective date are authorized to be made and completed on or before such effective date.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD08314-01-1

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the public health law, in relation to labeling prescription bottles of opioids

Purpose

This bill will require manufacturers and software companies that prepare labels for prescription drugs, which are approved by the state, to contain a warning regarding the addictive properties of opioid drugs.

Summary of provisions

Section one amends subdivision 2 of section 3333 of the Public Health Law by adding paragraph (d), providing that a new warning must be added to the labels of prescription bottles containing opioid drugs. The warning will read: "Warning. This drug is highly addictive and may cause depression and overdose. Please consult your pharmacist or physician before using."

Section two provides the effective Date

Justification

New Yorkers who are prescribed opioid medications should be aware of the potential dangers every time they reach for the bottle. The unprecedented rise in opioid addiction and deaths proves that we must do more to combat the current crisis. The number of Americans we lose each year to suicide and unintentional overdose has increased more than 250% since 2000. In 2017, over 40% of suicide and overdose deaths were known to have involved opioids, and rates are likely higher due to unrecorded opioid involvement.

Legislative history

2019-20: S6630 - referred to Health FISCAL IMPLICATIONS: None to the State.

Effective date

This act shall take effect ninety days after it shall have become law, and provides that any rule or regulation necessary for the implementa- tion of this act on its effective date are authorized to be made and completed on or before such effective date.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.